Research Applications
Pediatric Growth Disorders (Approved)
FDA-approved for GH deficiency, Turner syndrome, Prader-Willi syndrome, SGA, idiopathic short stature, Noonan syndrome, and SHOX deficiency.
Adult GH Deficiency (Approved)
FDA-approved for adult GHD showing improved body composition, bone density, cardiovascular risk profile, and quality of life.
Anti-Aging Research
Controversial use for age-related GH decline. TRIIM trial demonstrated thymic regeneration and epigenetic age reversal in healthy men treated with GH + DHEA + metformin.
AIDS Wasting (Approved)
FDA-approved (Serostim) for HIV-associated wasting and cachexia.
Mechanism of Action
hGH binds to the GH receptor (GHR) — a type I cytokine receptor — on target cells, causing receptor dimerization and activation of the JAK2 tyrosine kinase. JAK2 phosphorylates STAT5b (the primary GH signaling mediator), STAT1, and STAT3. Nuclear STAT5b drives IGF-1 gene transcription in liver and other tissues. GH also directly activates MAPK/ERK (cell proliferation), PI3K/Akt (metabolic effects), and SRC kinases. Direct GH effects include lipolysis in adipose tissue, protein synthesis in muscle, and sodium/water retention in kidneys.
Biological Pathways
GHR/JAK2/STAT5b for IGF-1 production. GHR/MAPK/ERK for cell proliferation. GHR/PI3K/Akt for glucose uptake (acute) and insulin resistance (chronic). GHR/SRC for metabolic regulation. Direct lipolytic pathway via HSL/ATGL activation in adipocytes.
Dosage Information
Calculation Results
Syringe Fill Level (100u syringe)
Protocols
No protocols featuring this peptide yet.
Browse All ProtocolsStability & Storage
Recombinant hGH is supplied as lyophilized powder or liquid formulations. Store at 2-8°C (liquid) or room temperature (lyophilized, depending on formulation). Long-acting formulations (somapacitan, lonapegsomatropin) provide weekly dosing. Sensitive to shaking, heat, and freezing. hGH is a protein — not a small peptide — requiring careful handling.
Side Effects & Precautions
Fluid retention (edema), arthralgia, carpal tunnel syndrome, insulin resistance/hyperglycemia, headache. In children: slipped capital femoral epiphysis, progression of scoliosis, intracranial hypertension. Long-term concerns about potential cancer risk (IGF-1 is a growth factor), though clinical data is reassuring for approved indications. Acromegalic features with chronic supraphysiological dosing.
Research Use Only. This information is for educational and research purposes only. Not intended for medical advice or self-medication.
Regulatory Status
FDA-approved under multiple brand names: Genotropin, Humatrope, Norditropin, Nutropin, Saizen, Serostim, Zomacton, Sogroya (long-acting). Controlled substance (Schedule III in some US states). WADA-prohibited under S2. Available by prescription only.
Research Studies
Growth Hormone in Adults: Physiology and Clinical Applications
Molitch ME, Clemmons DR, Malozowski S, et al.
TRIIM Trial: Reversal of Epigenetic Aging with GH/DHEA/Metformin
Fahy GM, Brooke RT, Watson JP, et al.
Recombinant Human Growth Hormone: First Therapeutic Protein
Goeddel DV, Heyneker HL, Hozumi T, et al.
Related Peptides

Sermorelin
Sermorelin Acetate, GRF 1-29 +3 more

CJC-1295
CJC-1295 DAC, CJC-1295 with DAC +3 more

GHRP-2
Growth Hormone Releasing Peptide 2, Pralmorelin +3 more

GHRP-6
Growth Hormone Releasing Peptide 6, Growth Hormone Releasing Hexapeptide +3 more

Hexarelin
Examorelin, HEX +2 more

Ipamorelin
IPA, NNC 26-0161 +2 more
